Tech Company M&A Transactions
Flexus Biosciences Acquisition
On 2/23/2015, Flexus Biosciences was acquired by Bristol-Meyers Squibb. Bristol-Meyers Squibb said the transaction price was $1.3 billion.
Transaction Overview
Company Name
Acquired By
Announced On
2/23/2015
Transaction Type
M&A
Amount
$1,250,000,000
M&A Terms
The transaction has a potential total consideration of $1.25 billion, including $800 million upfront and development milestones that, upon achievement, could total up to $450 million.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
75 Shoreway Road D
San Carlos, CA 94070
USA
San Carlos, CA 94070
USA
Phone
Undisclosed
Website
Email Address
Overview
Founded with the mission to create new cancer therapeutics through an innovative application of unexploited insights in immunology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Terry Rosen
VP - Engineering
Steve Young
Browse more venture capital transactions:
Prev: 2/23/2015: STAND venture capital transaction
Next: 2/24/2015: DriverUp venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC transactions on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs